# Kiora Stock Volatility

KPRX | Stock | ## USD 8.28 0.63 8.24% |

Kiora Pharmaceuticals has Sharpe Ratio of -0.0097, which conveys that the firm had -0.0097% of return per unit of risk over the last 3 months. Macroaxis standpoint towards estimating the risk of any stock is to look at both systematic and unsystematic factors of the business, including all available market data and technical indicators. Kiora Pharmaceuticals exposes twenty-eight different technical indicators, which can help you to evaluate volatility that cannot be diversified away. Please be advised to verify Kiora Pharmaceuticals risk adjusted performance of (0.013332), and Mean Deviation of 8.39 to check out the risk estimate we provide.

Kiora |

Kiora Pharmaceuticals Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Kiora daily returns, and it is calculated using variance and standard deviation. We also use Kiora's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Kiora Pharmaceuticals volatility.

### 60 Days Market Risk

### Chance of Distress

### 60 Days Economic Sensitivity

Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Kiora Pharmaceuticals can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Kiora Pharmaceuticals at lower prices. For example, an investor can purchase Kiora stock that has halved in price over a short period. This will lower your average cost per share, thereby improving your portfolio's performance when the markets normalize. Similarly, when the prices of Kiora Pharmaceuticals' stock rises, investors can sell out and invest the proceeds in other equities with better opportunities. Investing when markets are volatile with better valuations will accord both investors and companies the opportunity to generate better long-term returns.

## Moving against Kiora Pharmaceuticals

## Kiora Pharmaceuticals Market Sensitivity And Downside Risk

Kiora Pharmaceuticals' beta coefficient measures the volatility of Kiora stock compared to the systematic risk of the entire stock market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Kiora stock's returns against your selected market. In other words, Kiora Pharmaceuticals's beta of -3.2 provides an investor with an approximation of how much risk Kiora Pharmaceuticals stock can potentially add to one of your existing portfolios.

Kiora Pharmaceuticals is displaying above-average volatility over the selected time horizon. Investors should scrutinize Kiora Pharmaceuticals independently to ensure intended market timing strategies are aligned with expectations about Kiora Pharmaceuticals volatility. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Kiora Pharmaceuticals' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Kiora Pharmaceuticals' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall. 3 Months Beta |Analyze Kiora Pharmaceuticals Demand TrendCheck current 90 days Kiora Pharmaceuticals correlation with market (DOW)## Kiora Beta |

Kiora standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. Typical volatile equity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.

## Standard Deviation | 15.93 |

It is essential to understand the difference between upside risk (as represented by Kiora Pharmaceuticals's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Kiora Pharmaceuticals' daily returns or price. Since the actual investment returns on holding a position in kiora stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Kiora Pharmaceuticals.

## Kiora Pharmaceuticals Stock Volatility Analysis

Volatility refers to the frequency at which Kiora Pharmaceuticals stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Kiora Pharmaceuticals' price changes. Investors will then calculate the volatility of Kiora Pharmaceuticals' stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Kiora Pharmaceuticals' volatility:

### Historical Volatility

This type of stock volatility measures Kiora Pharmaceuticals' fluctuations based on previous trends. It's commonly used to predict Kiora Pharmaceuticals' future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.### Implied Volatility

This type of volatility provides a positive outlook on future price fluctuations for Kiora Pharmaceuticals' current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Kiora Pharmaceuticals' to be redeemed at a future date.Transformation |

The output start index for this execution was zero with a total number of output elements of sixty-one. The Median Price line plots median indexes of Kiora Pharmaceuticals price series..

## Kiora Pharmaceuticals Projected Return Density Against Market

Given the investment horizon of 90 days Kiora Pharmaceuticals has a beta of -3.2037 . This indicates as returns on its benchmark rise, returns on holding Kiora Pharmaceuticals are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, Kiora Pharmaceuticals is expected to outperform its benchmark.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kiora Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kiora Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kiora stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.

The company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Kiora Pharmaceuticals is significantly underperforming DOW. Predicted Return Density |

Returns |

## What Drives a Kiora Pharmaceuticals Price Volatility?

Several factors can influence a Stock's stock volatility:### Industry

Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.### Political and Economic environment

When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.### The Company's Performance

Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.## Kiora Pharmaceuticals Stock Risk Measures

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Kiora Pharmaceuticals or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Kiora Pharmaceuticals' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Kiora stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision. Given the investment horizon of 90 days the coefficient of variation of Kiora Pharmaceuticals is -10347.41. The daily returns are distributed with a variance of 253.82 and standard deviation of 15.93. The mean deviation of Kiora Pharmaceuticals is currently at 8.66. For similar time horizon, the selected benchmark (DOW) has volatility of 1.24

α | Alpha over DOW | -0.48 | |

β | Beta against DOW | -3.2 | |

σ | Overall volatility | 15.93 | |

Ir | Information ratio | -0.02 |

## Kiora Pharmaceuticals Stock Return Volatility

Kiora Pharmaceuticals historical daily return volatility represents how much of Kiora Pharmaceuticals stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 15.9318% risk (volatility on return distribution) over the 90 days horizon. By contrast, DOW inherits 1.2555% risk (volatility on return distribution) over the 90 days horizon. Performance (%) |

Timeline |

## About Kiora Pharmaceuticals Volatility

Volatility is a rate at which the price of Kiora Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Kiora Pharmaceuticals may increase or decrease. In other words, similar to Kiora's beta indicator, it measures the risk of Kiora Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Kiora Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.

Please read more on our technical analysis page.Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Kiora Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Salt Lake City, Utah. Kiora Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.

## Kiora Pharmaceuticals Investment Opportunity

Kiora Pharmaceuticals has a volatility of 15.93 and is 12.64 times more volatile than DOW.**96**of all equities and portfolios are less risky than Kiora Pharmaceuticals. Compared to the overall equity markets, volatility of historical daily returns of Kiora Pharmaceuticals is higher than

**96 ()**of all global equities and portfolios over the last 90 days. Use Kiora Pharmaceuticals to enhance the returns of your portfolios. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a very speculative upward sentiment. Check odds of Kiora Pharmaceuticals to be traded at $10.35 in 90 days.

### Very good diversification

The correlation between Kiora Pharmaceuticals and DJI is

**-0.25**(i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Kiora Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.## Kiora Pharmaceuticals Additional Risk Indicators

The analysis of Kiora Pharmaceuticals' secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Kiora Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some common measures of Kiora Pharmaceuticals stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.

Risk Adjusted Performance | (0.013332) | |||

Market Risk Adjusted Performance | 0.1023 | |||

Mean Deviation | 8.39 | |||

Coefficient Of Variation | (5,484) | |||

Standard Deviation | 15.66 | |||

Variance | 245.31 | |||

Information Ratio | (0.015192) |

Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

## Kiora Pharmaceuticals Suggested Diversification Pairs

Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.

The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Kiora Pharmaceuticals as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Kiora Pharmaceuticals' systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Kiora Pharmaceuticals' unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Kiora Pharmaceuticals.

Please see Correlation Analysis. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

## Complementary Tools for analysis

When running Kiora Pharmaceuticals price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Pair CorrelationCompare performance and examine fundamental relationship between any two equity instruments | Go | |

Watchlist OptimizationOptimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm | Go | |

CEO DirectoryScreen CEOs from public companies around the world | Go | |

Portfolio SuggestionGet suggestions outside of your existing asset allocation including your own model portfolios | Go | |

ETF DirectoryFind actively traded Exchange Traded Funds (ETF) from around the world | Go |

Is Kiora Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiora Pharmaceuticals. If investors know Kiora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiora Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Kiora Pharmaceuticals is measured differently than its book value, which is the value of Kiora that is recorded on the company's balance sheet. Investors also form their own opinion of Kiora Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiora Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiora Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiora Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Kiora Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Kiora Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiora Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.